Triple therapy for obese patients with type 2 diabetes: evaluating effectiveness of the metformin + exenatide + glibenclamide combination
The questions of phased management of metabolic disorders in patients with type 2 diabetes with obesity are considered. The advantages of various triple therapy regimens depending on the objectives and key pathogenic defects are demonstrated. Results of a clinical trial substantiating different trea...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2015-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/293 |